X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
index medicus (73) 73
male (69) 69
oncology (67) 67
female (65) 65
middle aged (65) 65
aged (59) 59
adult (41) 41
chemotherapy (32) 32
cancer (30) 30
aged, 80 and over (28) 28
treatment outcome (28) 28
radiotherapy (24) 24
care and treatment (23) 23
survival (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
neoplasm staging (18) 18
prognosis (18) 18
retrospective studies (18) 18
therapy (18) 18
article (16) 16
pancreatic neoplasms - drug therapy (16) 16
radiology, nuclear medicine & medical imaging (16) 16
fluorouracil - administration & dosage (15) 15
survival rate (15) 15
trial (15) 15
abridged index medicus (14) 14
deoxycytidine - analogs & derivatives (14) 14
disease-free survival (14) 14
gemcitabine (14) 14
pancreatic neoplasms - pathology (14) 14
surgery (14) 14
bevacizumab (13) 13
colorectal cancer (13) 13
pancreatic cancer (13) 13
patients (13) 13
antineoplastic agents - therapeutic use (12) 12
radiology (12) 12
survival analysis (12) 12
carcinoma, hepatocellular - pathology (11) 11
chemoradiation (11) 11
chemoradiotherapy (11) 11
liver neoplasms - drug therapy (11) 11
liver neoplasms - pathology (11) 11
medicine & public health (11) 11
mutation (11) 11
radiotherapy dosage (11) 11
adenocarcinoma (10) 10
capecitabine (10) 10
follow-up studies (10) 10
hematology, oncology and palliative medicine (10) 10
hepatocellular carcinoma (10) 10
pancreatic neoplasms - mortality (10) 10
patient outcomes (10) 10
radiation (10) 10
analysis (9) 9
antibodies, monoclonal, humanized (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
carcinoma, hepatocellular - drug therapy (9) 9
deoxycytidine - administration & dosage (9) 9
fluorouracil (9) 9
neoadjuvant therapy (9) 9
pancreatic neoplasms - radiotherapy (9) 9
research (9) 9
resection (9) 9
tumors (9) 9
adenocarcinoma - drug therapy (8) 8
biopsy (8) 8
hepatoma (8) 8
kaplan-meier estimate (8) 8
liver neoplasms - mortality (8) 8
liver neoplasms - secondary (8) 8
medical research (8) 8
medicine, experimental (8) 8
metastasis (8) 8
phase-ii (8) 8
radiology and nuclear medicine (8) 8
adenocarcinoma - mortality (7) 7
adenocarcinoma - pathology (7) 7
carcinoma, hepatocellular - mortality (7) 7
chemoradiotherapy - adverse effects (7) 7
chemoradiotherapy - methods (7) 7
combined modality therapy (7) 7
fluorouracil - analogs & derivatives (7) 7
fluorouracil - therapeutic use (7) 7
neoplasms (7) 7
prospective studies (7) 7
toxicity (7) 7
angiogenesis (6) 6
antibodies, monoclonal - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
bile duct neoplasms - pathology (6) 6
camptothecin - analogs & derivatives (6) 6
carcinoma (6) 6
cholangiocarcinoma - pathology (6) 6
colorectal neoplasms - drug therapy (6) 6
colorectal neoplasms - pathology (6) 6
deoxycytidine - therapeutic use (6) 6
drug therapy (6) 6
liver neoplasms - radiotherapy (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 10/2007, Volume 25, Issue 30, pp. 4787 - 4792
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 48 - 54
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 18, pp. 3027 - 3035
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 153 - 158
Purpose Chemoradiation for anal cancer yields effective tumor control, but is associated with significant acute toxicity. We report our multi-institutional... 
Radiology | Hematology, Oncology and Palliative Medicine | IMRT | Anal cancer | Chemoradiation | Acute toxicity | CANAL CARCINOMA | RANDOMIZED-TRIAL | PHASE-II | MITOMYCIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | HIV-POSITIVE PATIENTS | SQUAMOUS-CELL CARCINOMA | TREATMENT TOLERANCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Tumor Burden - radiation effects | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Urogenital System - radiation effects | Gastrointestinal Tract - radiation effects | Male | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma, Squamous Cell - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Fluorouracil - administration & dosage | Female | Retrospective Studies | Radiodermatitis - etiology | Lymphatic Irradiation - methods | Radiotherapy Dosage | Chemoradiotherapy - methods | Anus Neoplasms - diagnostic imaging | Actuarial Analysis - methods | Radiotherapy, Intensity-Modulated - methods | Treatment Outcome | Anus Neoplasms - pathology | Radiography | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Hematologic Diseases - etiology | Anus Neoplasms - radiotherapy | Carcinoma, Squamous Cell - secondary | Drug Substitution | Mitomycin - administration & dosage | Care and treatment | Radiotherapy | Nuclear radiation | Health aspects | Cancer | Toxicity | Canals | Radiation | Radiation therapy | Survival | Metastases | Chemotherapy | Immunosuppression | Age | Tumors | squamous cell carcinoma | Index Medicus | PATIENTS | AIDS VIRUS | RECTUM | BIOPSY | METASTASES | FEMALES | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | MEDICAL ESTABLISHMENTS | PLANNING | IMMUNOSUPPRESSION | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
Journal Article
Journal Article
Annals of Surgery, ISSN 0003-4932, 2015, Volume 261, Issue 1, pp. 12 - 17
Purpose: On the basis of the ACCORD trial, FOLFIRINOX is effective in metastatic pancreatic adenocarcinoma (PDAC), making it a rational choice for locally... 
Neoadjuvant therapy | Chemotherapy | FOLFIRINOX | PDAC | Surgery | Downstaging | Pancreas cancer | Pancreatic adenocarcinoma | 1423 PANCREATICODUODENECTOMIES | pancreatic adenocarcinoma | SURGEONS CONTRIBUTION | LONG-TERM SURVIVAL | MINIMAL POSTOPERATIVE COMPLICATIONS | ADENOCARCINOMA | PHASE-II | chemotherapy | neoadjuvant therapy | GEMCITABINE | CHEMORADIATION | pancreas cancer | RADIOTHERAPY | SINGLE-INSTITUTION EXPERIENCE | downstaging | surgery | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Humans | Middle Aged | Male | Pancreaticoduodenectomy | Chemoradiotherapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Neoadjuvant Therapy | Pancreatic Neoplasms - mortality | Retrospective Studies | Imaging, Three-Dimensional | Camptothecin - analogs & derivatives | Spiral Cone-Beam Computed Tomography | Pancreatic Neoplasms - pathology | Pancreatectomy | Treatment Outcome | Disease-Free Survival | Magnetic Resonance Imaging | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Adenocarcinoma - diagnostic imaging | Neoplasm Staging | Pancreatic Neoplasms - diagnostic imaging | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy
Journal Article
CardioVascular and Interventional Radiology, ISSN 0174-1551, 4/2014, Volume 37, Issue 2, pp. 381 - 387
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 830 - 838
Purpose To evaluate the safety, efficacy and biomarkers of short-course proton beam radiation and capecitabine, followed by pancreaticoduodenectomy in a phase... 
Radiology | Hematology, Oncology and Palliative Medicine | RECTAL-CANCER | ONCOLOGY-GROUP | ONCOLOGY | RESECTION | LONG-TERM SURVIVAL | RANDOMIZED CONTROLLED-TRIAL | PERIAMPULLARY CARCINOMA | SHORT-COURSE RADIOTHERAPY | FAILURE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | RADIATION-THERAPY | Pancreatic Neoplasms - chemistry | Proto-Oncogene Proteins p21(ras) | Receptors, CXCR - analysis | Prognosis | Prospective Studies | Capecitabine | Carcinoembryonic Antigen - blood | Humans | Middle Aged | Male | Pancreaticoduodenectomy | Chemoradiotherapy, Adjuvant - mortality | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Proto-Oncogene Proteins - analysis | Aged, 80 and over | Carcinoma, Pancreatic Ductal - mortality | Female | Pancreatic Neoplasms - mortality | CA-19-9 Antigen - blood | Genes, ras - genetics | Pancreatic Neoplasms - blood | Fluorouracil - analogs & derivatives | Biomarkers, Tumor - analysis | Pancreatic Neoplasms - pathology | Carcinoma, Pancreatic Ductal - therapy | ras Proteins - analysis | Carcinoma, Pancreatic Ductal - pathology | Chemoradiotherapy, Adjuvant - methods | Carcinoma, Pancreatic Ductal - blood | Carcinoma, Pancreatic Ductal - chemistry | Antimetabolites, Antineoplastic - therapeutic use | Hepatocyte Growth Factor - blood | Aged | Proton Therapy - methods | Deoxycytidine - analogs & derivatives | Pancreatic Neoplasms - therapy | Adenocarcinoma | Sects | Nuclear radiation | Index Medicus | SURGERY | GLYCINE | PATIENTS | BIOPSY | GENE MUTATIONS | PANCREAS | PROTON BEAMS | RADIATION DOSES | TOXICITY | CHEST | PAIN | BIOLOGICAL MARKERS | ASPARTIC ACID | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BLOOD
Journal Article